medicines evaluation board
Responsibility for assessing, authorising and for monitoring the
safety of human medicinal products lies with a Board consisting of
doctors, pharmacists and scientists. This Medicines Evaluation
Board (MEB) has autonomous powers to take decisions on the
availability of these medicinal products. The MEB is responsible
for authorising and monitoring safe and effective medicinal
products on the Dutch market and shares responsibility for
authorising medicinal products throughout the European Union.
Board membership
The MEB consists of a chairman and at least nine to a
maximum of seventeen other members (doctors, pharmacists and
scientists). The chairman and members are appointed by the Minister
for Health, Welfare and Sport.
The chairman and members are appointed for a four-year term and can
be reappointed for a further four years. The MEB’s operating
modalities and responsibilities are laid down in the Dutch
Medicines Act (Geneesmiddelenwet).
MEB Agency
The members of the Board are supported in their work by the
over 220 employees of the MEB Agency. As part of the Ministry
of Health, Welfare and Sport, the Agency is responsible for
preparing and implementing the MEB’s decisions and for coordinating
pharmacovigilance in the Netherlands.
The Agency also performs assessments of veterinary medicines via
the Veterinary Medicines Unit and the evaluation of novel foods via
the Novel Foods Unit. However, the Board is not responsible for
decisions and authorisation regarding veterinary medicinal products
and novel foods.
The Veterinary Medicines Unit prepares the decisions for the
Veterinary Medicinal Products Authorisation Committee. This
Committee advises the Minister for Agriculture, Nature and Food
Quality and the Minister for Health, Welfare and Sport, who are
responsible for policy and share the political responsibility.
In the Netherlands, the competent authority for assessing Novel
Foods is the Ministry of Health, Welfare and Sport. The Ministry
then asks the Novel Foods Unit of the MEB Agency to conduct a
scientific assessment of the product to determine consumer
safety.
MEB meetings
You can find agendas and minutes of MEB meetings on the
News page in the Human Medicines section.
For more information about a particular MEB member, please click on
the name. This will give you more details about the particular
member along with a short CV and declaration of interests.
Secretaries
Drs. A.A.W. Kalis (first secretary)
Mrs. drs. A.G. Kruger-Peters (undersecretary)
Drs. F.W. Weijers (undersecretary)
Drs. A.H.P. van Gompel (undersecretary)
Drs. D.S. Slijkerman (undersecretary)
Mrs. drs. K.H. Doorduyn-van der Stoep (vice-secretary)
Mrs. drs. G.M. Janse-de Hoog (vice-secretary)
Drs. E. van Galen (vice-secretary)
Drs. I.M. Mulder-van Dam (vice-secretary)
Drs. W.J. van Brussel (vice-secretary)
Drs. I.A.M.J. Leentjes (vice-secretary)
Ir. H. Stevenson (vice-secretary)
Drs. S.H. Ebbinge (vice-secretary)
Dr. A.H.G.J. Schrijvers (vice-secretary)
Drs. P.M. Prent (vice-secretary)
Drs. W.H. Woldring (vice-secretary)
Drs. E. Hergarden (vice-secretary)
Drs. C.J. Jonker (vice-secretary)
Dr. M.E.M.J. van Kuijk-Meuwissen (vice-secretary)
Drs. J. Kampmeijer (vice-secretary)
Go back »
